https://www.worldpharmaceuticals.net/news/genevant-sciences-to-collaborate-with-novo-nordisk-to-develop-gene-editing-treatment-for-hemophilia-a/ 2023-11-07T14:02:16+00:00 https://www.worldpharmaceuticals.net/news/shareholders-of-abcam-approve-proposed-acquisition-by-danaher/ 2023-11-07T14:09:25+00:00 https://www.worldpharmaceuticals.net/news/dewpoint-therapeutics-and-evotec-partner-to-advance-oncology-pipeline/ 2023-11-08T09:07:08+00:00 https://www.worldpharmaceuticals.net/news/jazz-pharmaceuticals-md-anderson-to-study-zanidatamab-in-her2-expressing-cancers/ 2023-11-08T14:04:49+00:00 https://www.worldpharmaceuticals.net/news/glenmark-pharma-receives-anda-approval-for-fluphenazine-hydrochloride-tablets-usp-1-mg-2-5-mg-5-mg-and-10-mg/ 2023-11-08T14:25:50+00:00 https://www.worldpharmaceuticals.net/news/alfasigma-wraps-up-acquisition-of-intercept-pharmaceuticals/ 2023-11-09T07:14:04+00:00 https://www.worldpharmaceuticals.net/news/lillys-tirzepatide-authorised-in-us-uk/ 2023-11-09T09:11:58+00:00 https://www.worldpharmaceuticals.net/news/takeda-gets-fda-nod-for-fruzaqla-to-treat-metastatic-colorectal-cancer/ 2023-11-09T09:28:30+00:00 https://www.worldpharmaceuticals.net/news/tremfya-delivers-clinically-meaningful-improvements-in-real-world-psa-outcomes/ 2023-11-09T13:53:58+00:00 https://www.worldpharmaceuticals.net/news/porton-advanced-announces-a-strategic-partnership-with-biomap-with-ai-models-facilitating-aav-gene-therapy-development/ 2023-11-09T13:56:04+00:00 https://www.worldpharmaceuticals.net/news/tempus-announces-research-collaboration-with-bristol-myers-squibb-to-apply-multimodal-ai-approaches/ 2023-11-09T14:00:56+00:00 https://www.worldpharmaceuticals.net/news/novartis-positive-data-for-remibrutinib-oral-treatment-csu/ 2023-11-10T06:48:30+00:00 https://www.worldpharmaceuticals.net/news/astrazeneca-signs-licence-deal-with-eccogene-for-obesity-drug-candidate/ 2023-11-10T08:58:07+00:00 https://www.worldpharmaceuticals.net/news/us-fda-approves-takedas-adzynma-for-congenital-ttp-treatment/ 2023-11-10T09:29:38+00:00 https://www.worldpharmaceuticals.net/news/bayer-recursion-update-research-partnership-for-precision-oncology/ 2023-11-10T12:32:52+00:00 https://www.worldpharmaceuticals.net/news/ec-approves-daiichi-sankyos-vanflyta-for-flt3-itd-positive-aml/ 2023-11-10T13:21:53+00:00 https://www.worldpharmaceuticals.net/news/genscript-probio-curocell-viral-vector-production-for-car-t-therapy/ 2023-11-13T06:19:39+00:00 https://www.worldpharmaceuticals.net/news/fda-approves-paciras-exparel-expanded-label-for-two-new-nerve-block-indications/ 2023-11-13T08:32:53+00:00 https://www.worldpharmaceuticals.net/news/novo-nordisk-manufacturing-facilities-expansion/ 2023-11-13T08:47:23+00:00 https://www.worldpharmaceuticals.net/news/telix-doses-first-patient-in-phase-3-prostact-global-study-of-tlx591/ 2023-11-13T12:13:35+00:00 https://www.worldpharmaceuticals.net/news/rznomics-roche-partner-to-evaluate-rz-001-with-atezolizumab/ 2023-11-13T13:10:36+00:00 https://www.worldpharmaceuticals.net/news/sandoz-inaugurates-new-antibiotic-production-plant-in-austria-and-new-biosimilar-development-center-in-germany/ 2023-11-13T14:13:34+00:00 https://www.worldpharmaceuticals.net/news/io-biotech-completes-enrollment-of-380-patients-in-pivotal-phase-3-trial-in-advanced-melanoma/ 2023-11-13T14:18:43+00:00 https://www.worldpharmaceuticals.net/news/charles-river-aitia-collaborate-on-ai-powered-drug-discovery-solution/ 2023-11-14T06:51:09+00:00 https://www.worldpharmaceuticals.net/news/ajinomoto-to-purchase-us-based-cdmo-forge/ 2023-11-14T08:56:57+00:00 https://www.worldpharmaceuticals.net/news/ipsen-medison-get-health-canada-approval-for-bylvay-in-pfic-related-pruritus/ 2023-11-14T13:28:29+00:00 https://www.worldpharmaceuticals.net/news/teva-and-royalty-pharma-collaborate-to-further-accelerate-olanzapine-lai-program/ 2023-11-14T18:30:49+00:00 https://www.worldpharmaceuticals.net/news/almirall-announces-ai-drug-discovery-partnership-with-absci/ 2023-11-15T06:34:27+00:00 https://www.worldpharmaceuticals.net/news/imfinzi-with-chemoradiotherapy-fails-to-meet-pfs-endpoint-in-phase-3-trial/ 2023-11-15T07:59:31+00:00 https://www.worldpharmaceuticals.net/news/xarelto-plus-aspirin-meets-primary-endpoints-in-phase-3-study/ 2023-11-15T11:18:46+00:00 https://www.worldpharmaceuticals.net/news/astellas-to-acquire-propella-for-175m/ 2023-11-16T08:58:02+00:00 https://www.worldpharmaceuticals.net/news/gileads-oncology-firm-kite-expands-existing-partnership-with-arcellx/ 2023-11-16T09:48:43+00:00 https://www.worldpharmaceuticals.net/news/bms-gets-fda-nod-for-augtyro-to-treat-ros1-positive-nsclc/ 2023-11-16T13:08:29+00:00 https://www.worldpharmaceuticals.net/news/vertex-crispr-secure-uk-mhra-approval-for-casgevy-to-treat-scd-and-tdt/ 2023-11-17T08:05:51+00:00 https://www.worldpharmaceuticals.net/news/eli-lilly-plans-to-build-e2bn-production-plant-in-germany/ 2023-11-17T09:14:13+00:00 https://www.worldpharmaceuticals.net/news/mercks-keytruda-combo-gets-us-fda-approval-for-gastric-cancer/ 2023-11-17T14:09:43+00:00 https://www.worldpharmaceuticals.net/news/postera-announces-a-research-collaboration-with-amgen-to-discover-small-molecule-therapeutics-using-ai/ 2023-11-18T17:21:08+00:00 https://www.worldpharmaceuticals.net/news/us-fda-approves-astrazenecas-truqap-plus-faslodex-to-treat-hr-positive-breast-cancer/ 2023-11-20T08:55:18+00:00 https://www.worldpharmaceuticals.net/news/astrazeneca-health-technology-business-evinova/ 2023-11-21T08:54:45+00:00 https://www.worldpharmaceuticals.net/news/porton-advanced-ascle-partner-on-nk-cells-development-and-application/ 2023-11-21T12:22:52+00:00 https://www.worldpharmaceuticals.net/news/rion-mayo-clinic-and-the-u-s-army-medical-research-institute-for-chemical-defense-receive-2-4m-department-of-defense/ 2023-11-21T18:31:53+00:00 https://www.worldpharmaceuticals.net/news/merck-phase-ii-of-new-e29m-biologics-testing-center-china/ 2023-11-22T06:35:12+00:00 https://www.worldpharmaceuticals.net/news/beigene-ensem-cdk2-inhibitor-license/ 2023-11-22T08:43:05+00:00 https://www.worldpharmaceuticals.net/news/merck-to-buy-caraway-therapeutics-for-up-to-610m/ 2023-11-22T10:30:53+00:00 https://www.worldpharmaceuticals.net/news/genentech-nvidia-partner-to-expedite-drug-discovery-and-development/ 2023-11-22T12:38:46+00:00 https://www.worldpharmaceuticals.net/news/gsk-announces-major-step-towards-sustainability-ambitions-with-advancement-of-low-carbon-ventolin-programme-to-phase-iii-trials/ 2023-11-22T16:23:20+00:00 https://www.worldpharmaceuticals.net/news/myricx-bio-enters-into-an-exclusive-antibody-license-agreement-with-wuxi-biologics/ 2023-11-22T16:30:34+00:00 https://www.worldpharmaceuticals.net/news/nmpa-accepts-nda-for-anheart-ros1-inhibitor-taletrectinib/ 2023-11-23T06:50:59+00:00 https://www.worldpharmaceuticals.net/news/vivodyne-raises-38m-to-develop-lab-grown-human-organs-for-drug-testing/ 2023-11-23T14:23:21+00:00 https://www.worldpharmaceuticals.net/news/wuxi-biologics-successfully-implemented-a-fully-integrated-continuous-process-with-a-breakthrough-productivity-of-6-g-l-day-at-pilot-scale/ 2023-11-23T17:50:42+00:00 https://www.worldpharmaceuticals.net/news/bayer-invests-e130m-production-facility-for-parenteral-products-in-germany/ 2023-11-24T07:34:45+00:00 https://www.worldpharmaceuticals.net/news/novo-nordisk-invests-e2-1bn-to-expand-production-sites-in-france/ 2023-11-24T11:17:01+00:00 https://www.worldpharmaceuticals.net/news/fda-grants-orphan-drug-designation-to-ellipses-ep0031-a400-compound/ 2023-11-24T13:36:13+00:00 https://www.worldpharmaceuticals.net/news/arkbio-to-advance-ak0610-to-clinical-trials-after-ind-approval-in-china/ 2023-11-24T13:51:23+00:00 https://www.worldpharmaceuticals.net/news/chinas-nmpa-accepts-genfleets-nda-for-gfh925/ 2023-11-27T06:56:36+00:00 https://www.worldpharmaceuticals.net/news/everest-secures-nmpa-approval-for-nefecon/ 2023-11-27T09:02:39+00:00 https://www.worldpharmaceuticals.net/news/rusan-pharma-unveils-its-state-of-the-art-facility-for-apis-in-pithampur-madhya-pradesh/ 2023-11-27T15:50:03+00:00 https://www.worldpharmaceuticals.net/news/blenrep-meets-primary-endpoint-in-phase-3-multiple-myeloma-trial/ 2023-11-28T08:35:32+00:00 https://www.worldpharmaceuticals.net/news/springworks-secures-fda-approval-of-ogsiveo/ 2023-11-28T08:46:57+00:00 https://www.worldpharmaceuticals.net/news/boehringer-ingelheim-ibm-partner-to-expedite-antibody-discovery/ 2023-11-28T09:37:52+00:00 https://www.worldpharmaceuticals.net/news/dupixent-reduces-copd-exacerbations-in-second-phase-3-trial/ 2023-11-28T12:16:01+00:00 https://www.worldpharmaceuticals.net/news/arcturus-secures-fda-orphan-drug-designation-for-arct-032-in-cystic-fibrosis/ 2023-11-28T13:38:24+00:00 https://www.worldpharmaceuticals.net/news/aws-amgen-partner-on-generative-ai-solutions-for-advanced-therapies/ 2023-11-29T09:19:33+00:00 https://www.worldpharmaceuticals.net/news/merck-v116-shows-superior-immunogenicity-in-phase-3-trial/ 2023-11-29T11:55:51+00:00 https://www.worldpharmaceuticals.net/news/genethon-using-artificial-intelligence-to-improve-effectiveness-of-gene-therapies-and-patient-access/ 2023-11-29T12:15:24+00:00 https://www.worldpharmaceuticals.net/news/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target/ 2023-11-29T12:32:16+00:00 https://www.worldpharmaceuticals.net/news/abbvie-to-acquire-cancer-therapeutics-maker-immunogen-for-10-1bn/ 2023-12-01T08:46:23+00:00 https://www.worldpharmaceuticals.net/news/everest-medicines-etrasimod-meets-primary-endpoint-in-phase-3-uc-trial/ 2023-12-01T10:40:29+00:00 https://www.worldpharmaceuticals.net/news/qnovias-smoking-cessation-asset-qn-01-shows-superior-pharmacokinetic-profile-in-phase-1-trial/ 2023-12-01T12:34:10+00:00 https://www.worldpharmaceuticals.net/news/lilly-secures-fda-approval-for-jaypirca-to-treat-chronic-lymphocytic-leukaemia-or-small-lymphocytic-lymphoma-in-adults/ 2023-12-04T07:42:58+00:00 https://www.worldpharmaceuticals.net/news/pfizers-danuglipron-meets-primary-endpoint-in-phase-2b-obesity-trial/ 2023-12-04T11:15:47+00:00 https://www.worldpharmaceuticals.net/news/psychogenics-licenses-roches-ent1-inhibitor-for-neuropsychiatric-disorders-treatment/ 2023-12-04T13:51:12+00:00 https://www.worldpharmaceuticals.net/news/gc-biopharma-completes-construction-of-mrna-production-site-in-south-korea/ 2023-12-04T14:27:59+00:00 https://www.worldpharmaceuticals.net/news/sana-biotechnology-publishes-early-clinical-data-showing-that-sc291-a-cd19-directed-allogeneic-car-t-therapy-evades-immune-detection-in-presence-of-intact-immune-system/ 2023-12-04T17:47:43+00:00 https://www.worldpharmaceuticals.net/news/mytos-announces-19m-series-a-funding-to-automate-human-cell-manufacturing-and-further-accelerate-growth/ 2023-12-04T17:58:46+00:00 https://www.worldpharmaceuticals.net/news/roche-to-acquire-us-biotechnology-company-carmot/ 2023-12-05T08:55:12+00:00 https://www.worldpharmaceuticals.net/news/absci-astrazeneca-partner-to-develop-ai-based-oncology-candidate/ 2023-12-05T12:29:31+00:00 https://www.worldpharmaceuticals.net/news/seismic-therapeutic-raises-121m-to-advance-ml-optimised-immunology-pipeline/ 2023-12-05T14:26:16+00:00 https://www.worldpharmaceuticals.net/news/merck-licenses-abbiskos-pimicotinib-in-deal-worth-up-to-605-5m/ 2023-12-05T14:34:30+00:00 https://www.worldpharmaceuticals.net/news/oxford-properties-starts-work-on-ionis-carlsbad-campus-expansion/ 2023-12-06T06:53:14+00:00 https://www.worldpharmaceuticals.net/news/abbvie-bighat-partner-to-discover-therapeutic-antibodies/ 2023-12-06T07:25:07+00:00 https://www.worldpharmaceuticals.net/news/roches-inavolisib-combo-meets-primary-endpoint-in-phase-3-breast-cancer-trial/ 2023-12-06T10:36:19+00:00 https://www.worldpharmaceuticals.net/news/lillys-verzenio-fails-to-improve-os-in-phase-3-breast-cancer-trial/ 2023-12-06T12:37:28+00:00 https://www.worldpharmaceuticals.net/news/aqemia-sanofi-ink-140m-research-collaboration-deal-for-small-molecules/ 2023-12-06T13:49:11+00:00 https://www.worldpharmaceuticals.net/news/odyssey-therapeutics-announces-101-million-series-c-financing/ 2023-12-06T17:25:58+00:00 https://www.worldpharmaceuticals.net/news/abbvie-to-buy-cerevel-therapeutics-for-8-7bn/ 2023-12-07T07:25:19+00:00 https://www.worldpharmaceuticals.net/news/fda-approves-novartis-fabhalta-for-paroxysmal-nocturnal-hemoglobinuria/ 2023-12-07T09:09:05+00:00 https://www.worldpharmaceuticals.net/news/bms-abecma-receives-approval-in-japan-for-multiple-myeloma-treatment/ 2023-12-07T12:40:41+00:00 https://www.worldpharmaceuticals.net/news/naya-biosciences-announces-research-alliance-with-onk-therapeutics/ 2023-12-07T13:18:09+00:00 https://www.worldpharmaceuticals.net/news/igc-pharma-announces-collaboration-to-integrate-ai-into-clinical-trials/ 2023-12-07T14:24:04+00:00 https://www.worldpharmaceuticals.net/news/coya-therapeutics-dr-reddys-sign-licensing-deal-for-als-candidate-coya-302/ 2023-12-07T14:56:45+00:00 https://www.worldpharmaceuticals.net/news/artbio-secures-90m-to-advance-alpha-radioligand-therapies-pipeline/ 2023-12-08T13:06:52+00:00 https://www.worldpharmaceuticals.net/news/vanda-buys-us-canadian-rights-to-ponvory-from-actelion-for-100m/ 2023-12-08T13:22:32+00:00 https://www.worldpharmaceuticals.net/news/sarclisa-phase-3-trial-met-primary-endpoint-of-progression-free-survival-in-patients-with-newly-diagnosed-multiple-myeloma-not-eligible-for-transplant/ 2023-12-10T17:28:54+00:00 https://www.worldpharmaceuticals.net/news/arteraai-and-genesiscare-partner-to-launch-the-first-australian-based-clinical-trial/ 2023-12-10T17:38:51+00:00 https://www.worldpharmaceuticals.net/news/biontech-to-strengthen-local-mrna-ecosystem-victoria/ 2023-12-11T08:55:56+00:00 https://www.worldpharmaceuticals.net/news/novartis-iptacopan-meets-primary-endpoint-in-phase-3-trial-in-c3g/ 2023-12-11T14:04:23+00:00 https://www.worldpharmaceuticals.net/news/nona-biosciences-announces-collaboration-with-evive-biotech-to-accelerate-antibody-discovery/ 2023-12-11T14:15:36+00:00 https://www.worldpharmaceuticals.net/news/sigma-healthcare-chemist-warehouse-5-8bn-merger/ 2023-12-12T08:58:51+00:00 https://www.worldpharmaceuticals.net/news/jemperli-plus-chemo-has-received-ec-approval-for-endometrial-cancer/ 2023-12-12T12:40:30+00:00